{"count": 10, "results": [{"_id": "9279969", "pmid": 9279969, "title": "Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.", "journal": "Scand J Clin Lab Invest", "authors": ["Nielsen FS", "Rossing P", "Gall MA", "Smidt UM", "Chen JW", "Sato A", "Parving HH"], "date": "1997-08-01T00:00:00Z", "doi": "10.3109/00365519709084591", "meta_date_publication": "1997 Aug", "meta_volume": "57", "meta_issue": "5", "meta_pages": "427-34", "score": 50073.168, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ improves @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@hypertensive NIDDM@@@ subjects with @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@diabetic nephropathy@@@.", "citations": {"NLM": "Nielsen FS, Rossing P, Gall MA, Smidt UM, Chen JW, Sato A, Parving HH. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. Scand J Clin Lab Invest. 1997 Aug;57(5):427-34. PMID: 9279969", "BibTeX": "@article{9279969, title={Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.}, author={Nielsen FS and Rossing P and Gall MA and Smidt UM and Chen JW and Sato A and Parving HH}, journal={Scand J Clin Lab Invest}, volume={57}, number={5}, pages={427-34}}"}}, {"_id": "20545993", "pmid": 20545993, "title": "Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behcet's disease.", "journal": "Echocardiography", "authors": ["Inanc MT", "Kalay N", "Heyit T", "Ozdogru I", "Kaya MG", "Dogan A", "Duran M", "Kasapkara HA", "Gunebakmaz O", "Borlu M", "Yarlıoglues M", "Oguzhan A"], "date": "2010-09-01T00:00:00Z", "doi": "10.1111/j.1540-8175.2010.01180.x", "meta_date_publication": "2010 Sep", "meta_volume": "27", "meta_issue": "8", "meta_pages": "997-1003", "score": 50073.133, "text_hl": "Effects of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Behcet_Syndrome @DISEASE_MESH:D001528 @@@Behcet's disease@@@.", "citations": {"NLM": "Inanc MT, Kalay N, Heyit T, Ozdogru I, Kaya MG, Dogan A, Duran M, Kasapkara HA, Gunebakmaz O, Borlu M, Yarlıoglues M, Oguzhan A. Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behcet's disease. Echocardiography. 2010 Sep;27(8):997-1003. PMID: 20545993", "BibTeX": "@article{20545993, title={Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behcet's disease.}, author={Inanc MT and Kalay N and Heyit T and Ozdogru I and Kaya MG and Dogan A and Duran M and Kasapkara HA and Gunebakmaz O and Borlu M and Yarlıoglues M and Oguzhan A}, journal={Echocardiography}, volume={27}, number={8}, pages={997-1003}}"}}, {"_id": "28095251", "pmid": 28095251, "title": "Improvement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade?", "journal": "J Renin Angiotensin Aldosterone Syst", "authors": ["Wagenaar LJ", "Buikema H", "Pinto YM", "van Gilst WH"], "date": "2001-03-01T00:00:00Z", "doi": "10.1177/14703203010020011101", "meta_date_publication": "2001 Mar", "meta_volume": "2", "meta_issue": "1_suppl", "meta_pages": "S64-S69", "score": 50064.98, "text_hl": "Therefore we compared the effects of the ACE-I @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ vs. the ARB @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@ on @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ in a @SPECIES_10116 @@@rat@@@ model of @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@CHF@@@. ", "citations": {"NLM": "Wagenaar LJ, Buikema H, Pinto YM, van Gilst WH. Improvement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade? J Renin Angiotensin Aldosterone Syst. 2001 Mar;2(1_suppl):S64-S69. PMID: 28095251", "BibTeX": "@article{28095251, title={Improvement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade?}, author={Wagenaar LJ and Buikema H and Pinto YM and van Gilst WH}, journal={J Renin Angiotensin Aldosterone Syst}, volume={2}, number={1_suppl}, pages={S64-S69}}"}}, {"_id": "25306751", "pmid": 25306751, "title": "[Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].", "journal": "Ter Arkh", "authors": ["Statsenko ME", "Derevianchenko MV"], "date": "2014-01-01T00:00:00Z", "meta_date_publication": "2014", "meta_volume": "86", "meta_issue": "8", "meta_pages": "90-3", "score": 50064.65, "text_hl": "AIM: To evaluate the impact of 6-month antihypertensive therapy with the combined drug @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ + @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (ekvator) on @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ (@<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@ED@@@) and @CHEMICAL_Carbohydrates @CHEMICAL_MESH:D002241 @@@carbohydrate@@@ metabolic parameters in @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@DM@@@). ", "citations": {"NLM": "Statsenko ME, Derevianchenko MV. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy]. Ter Arkh. 2014;86(8):90-3. PMID: 25306751", "BibTeX": "@article{25306751, title={[Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].}, author={Statsenko ME and Derevianchenko MV}, journal={Ter Arkh}, volume={86}, number={8}, pages={90-3}}"}}, {"_id": "24261232", "pmid": 24261232, "title": "[Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus].", "journal": "Ter Arkh", "authors": ["Statsenko ME", "Derevianchenko MV", "Ostrovskiĭ OV", "Titarenko MN", "Shvets MK", "Bondarev AM"], "date": "2013-01-01T00:00:00Z", "meta_date_publication": "2013", "meta_volume": "85", "meta_issue": "9", "meta_pages": "63-8", "score": 50058.777, "text_hl": "AIM: To evaluate the impact of combination antihypertensive therapy with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ + @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (Ekvator) on @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and concurrent @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ (@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@). ", "citations": {"NLM": "Statsenko ME, Derevianchenko MV, Ostrovskiĭ OV, Titarenko MN, Shvets MK, Bondarev AM. [Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus]. Ter Arkh. 2013;85(9):63-8. PMID: 24261232", "BibTeX": "@article{24261232, title={[Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus].}, author={Statsenko ME and Derevianchenko MV and Ostrovskiĭ OV and Titarenko MN and Shvets MK and Bondarev AM}, journal={Ter Arkh}, volume={85}, number={9}, pages={63-8}}"}}, {"_id": "8206613", "pmid": 8206613, "title": "Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockade.", "journal": "Hypertension", "authors": ["Auch-Schwelk W", "Duske E", "Hink U", "Betz M", "Unkelbach M", "Fleck E"], "date": "1994-06-01T00:00:00Z", "doi": "10.1161/01.hyp.23.6.832", "meta_date_publication": "1994 Jun", "meta_volume": "23", "meta_issue": "6 Pt 2", "meta_pages": "832-7", "score": 50055.926, "text_hl": "@CHEMICAL_Cyclosporine @CHEMICAL_MESH:D016572 @@@Cyclosporin A@@@-induced @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ was prevented by cotreatment with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ or @CHEMICAL_ICI_D8731 @CHEMICAL_MESH:C081112 @@@D 8731@@@. ", "citations": {"NLM": "Auch-Schwelk W, Duske E, Hink U, Betz M, Unkelbach M, Fleck E. Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockade. Hypertension. 1994 Jun;23(6 Pt 2):832-7. PMID: 8206613", "BibTeX": "@article{8206613, title={Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockade.}, author={Auch-Schwelk W and Duske E and Hink U and Betz M and Unkelbach M and Fleck E}, journal={Hypertension}, volume={23}, number={6 Pt 2}, pages={832-7}}"}}, {"_id": "17047621", "pmid": 17047621, "title": "[Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease].", "journal": "Kardiologiia", "authors": ["Pribylov SA"], "date": "2006-01-01T00:00:00Z", "meta_date_publication": "2006", "meta_volume": "46", "meta_issue": "9", "meta_pages": "36-40", "score": 50053.465, "text_hl": "[@DISEASE_Hypertension_Pulmonary @DISEASE_MESH:D006976 @@@Pulmonary hypertension@@@, @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@, and their correction with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ in combination of @DISEASE_Myocardial_Ischemia @DISEASE_MESH:D017202 @@@ischemic heart disease@@@ and @DISEASE_Pulmonary_Disease_Chronic_Obstructive @DISEASE_MESH:D029424 @@@chronic obstructive pulmonary disease@@@].", "citations": {"NLM": "Pribylov SA. [Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease]. Kardiologiia. 2006;46(9):36-40. PMID: 17047621", "BibTeX": "@article{17047621, title={[Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease].}, author={Pribylov SA}, journal={Kardiologiia}, volume={46}, number={9}, pages={36-40}}"}}, {"_id": "20144153", "pmid": 20144153, "title": "[Evaluation of long-term therapy influence with angiotensin converting enzyme inhibitor lisinopril on morphofunctional parameters of the left ventricle, peripheral artery endothelium disfunction and painless myocardial ischemia in premenopausal women with hypertension].", "journal": "Kardiologiia", "authors": ["Khabibulina MM"], "date": "2010-01-01T00:00:00Z", "meta_date_publication": "2010", "meta_volume": "50", "meta_issue": "1", "meta_pages": "16-21", "score": 50051.33, "text_hl": "The results show that @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ therapy in premenopausal @SPECIES_9606 @@@women@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ can stop or even cause regression of @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@LV myocardial hypertrophy@@@ and produce favorable effect on @DISEASE_Ventricular_Remodeling @DISEASE_MESH:D020257 @@@LV remodeling@@@ mostly in @SPECIES_9606 @@@women@@@ with concentric type of @DISEASE_Hypertrophy @DISEASE_MESH:D006984 @@@hypertrophy@@@ and/or without @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@, and has positive effect on frequency of painless @DISEASE_Myocardial_Ischemia @DISEASE_MESH:D017202 @@@myocardial ischemia@@@ events.", "citations": {"NLM": "Khabibulina MM. [Evaluation of long-term therapy influence with angiotensin converting enzyme inhibitor lisinopril on morphofunctional parameters of the left ventricle, peripheral artery endothelium disfunction and painless myocardial ischemia in premenopausal women with hypertension]. Kardiologiia. 2010;50(1):16-21. PMID: 20144153", "BibTeX": "@article{20144153, title={[Evaluation of long-term therapy influence with angiotensin converting enzyme inhibitor lisinopril on morphofunctional parameters of the left ventricle, peripheral artery endothelium disfunction and painless myocardial ischemia in premenopausal women with hypertension].}, author={Khabibulina MM}, journal={Kardiologiia}, volume={50}, number={1}, pages={16-21}}"}}, {"_id": "22526544", "pmid": 22526544, "title": "Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.", "journal": "Psychopharmacology (Berl)", "authors": ["Sharma B", "Singh N"], "date": "2012-10-01T00:00:00Z", "doi": "10.1007/s00213-012-2718-9", "meta_date_publication": "2012 Oct", "meta_volume": "223", "meta_issue": "3", "meta_pages": "307-17", "score": 50047.957, "text_hl": "Treatments of NDDCT as well as @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ significantly attenuated @CHEMICAL_Desoxycorticosterone_Acetate @CHEMICAL_MESH:D064791 @@@DOCA@@@ @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@-induced @DISEASE_Learning_Disabilities @DISEASE_MESH:D007859 @@@impairment of learning and memory@@@, @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@, and changes in various biochemical levels. ", "citations": {"NLM": "Sharma B, Singh N. Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats. Psychopharmacology (Berl). 2012 Oct;223(3):307-17. PMID: 22526544", "BibTeX": "@article{22526544, title={Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.}, author={Sharma B and Singh N}, journal={Psychopharmacology (Berl)}, volume={223}, number={3}, pages={307-17}}"}}, {"_id": "11811369", "pmid": 11811369, "title": "Endothelial factors and microvascular hypertensive disease.", "journal": "J Cardiovasc Pharmacol", "authors": ["Rizzoni D", "Agabiti-Rosei E"], "date": "2001-11-01T00:00:00Z", "doi": "10.1097/00005344-200111002-00005", "meta_date_publication": "2001 Nov", "meta_volume": "38 Suppl 2", "meta_issue": "", "meta_pages": "S15-8", "score": 50040.863, "text_hl": "A significant improvement in @<m>DISEASE_Vascular_Diseases</m> @DISEASE_MESH:D014652 @@@endothelial dysfunction@@@ may be observed in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ after prolonged treatment with ACE inhibitors (@CHEMICAL_Cilazapril @CHEMICAL_MESH:D017315 @@@cilazapril@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@), @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ entry blockers (@CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@), and angiotensin II receptor blockers (@CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@), while @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@ and hydrochlorotiazide proved to be ineffective in this regard despite similar blood pressure reductions. ", "citations": {"NLM": "Rizzoni D, Agabiti-Rosei E. Endothelial factors and microvascular hypertensive disease. J Cardiovasc Pharmacol. 2001 Nov;38 Suppl 2():S15-8. PMID: 11811369", "BibTeX": "@article{11811369, title={Endothelial factors and microvascular hypertensive disease.}, author={Rizzoni D and Agabiti-Rosei E}, journal={J Cardiovasc Pharmacol}, volume={38 Suppl 2}, pages={S15-8}}"}}]}